Dementia
Disease State Hub
Featured
04/15/2024
Researchers set out to determine whether microglial activation, which can trigger neuroinflammation, is associated with neuropsychiatric symptoms that often accompany Alzheimer-associated dementias,...
04/15/2024
04/14/2024
Samar R El Khoudary, PhD, MPH, BPharm, FAHA
Samar R El Khoudary, PhD, MPH, BPharm, FAHA
In a long-term follow-up study, Samar R. El Khoudary, PhD, MPH, BPharm, FAHA, and colleagues investigated how the quantity and quality of cardiovascular fat in women with Alzheimer disease measured during...
04/14/2024
04/02/2024
Researchers sought to determine an association between people with hearing loss, their hearing aid use, and the possibility of an increased risk of dementia or Alzheimer disease.
04/02/2024
Interactive Features
02/22/2024
In their presentation at the Practical Updates in Primary Care 2023 Virtual Series, Craig Chepke, MD, DFAPA, and Kevin Williams, MS, MPAS, PA-C reviewed the pathophysiological mechanisms of agitation...
02/22/2024
12/02/2023
Your patient is a 46-year-old woman with a family history of dementia and obesity. Based on her family history, she asks you if there is a way to reduce her risk of developing dementia, and a way to stay...
12/02/2023
11/11/2023
Increasing age is a risk factor for Alzheimer dementia (AD), and as the US population grows older and lives longer, new and existing cases of AD are projected to rise as well. How many older Americans are...
11/11/2023
04/16/2023
Your patient is a 56-year-old woman with a family history of dementia. She asks you if her coffee intake would increase her risk of being diagnosed with dementia in the future.
04/16/2023
01/20/2020
Many patients with Alzheimer disease may become confused, anxious, aggressive, agitated, or restless consistently in the late afternoon or early evening. Do you know when this symptom, known as sundowning,...
01/20/2020
Clinical Insights
04/14/2024
Samar R El Khoudary, PhD, MPH, BPharm, FAHA
Samar R El Khoudary, PhD, MPH, BPharm, FAHA
In a long-term follow-up study, Samar R. El Khoudary, PhD, MPH, BPharm, FAHA, and colleagues investigated how the quantity and quality of cardiovascular fat in women with Alzheimer disease measured during...
04/14/2024
03/25/2024
Brenden P. Lucey, MD, MSCI
Brenden P. Lucey, MD, MSCI
In a small clinical trial, researchers found that patients taking suvorexant, an FDA-approved treatment for insomnia, had reduced levels of amyloid beta (amyloid-β) and tau phosphorylation proteins, which...
03/25/2024
01/28/2024
In this video, Gautam Dantas, PhD, discusses how the results of his study showed that altered gut bacteria may be an indicator of the earliest stages of Alzheimer disease.
01/28/2024
12/31/2023
In this interview, Emile d’Angremont, MSc, discusses the results of a recent study examining the use of cholinesterase inhibitors for the management of psychotic symptoms among patients with...
12/31/2023
12/28/2023
In this video, Gillian T. Coughlan, MS, PhD discusses her team's study results, which found that female sex, early-age menopause, and hormone therapy use beginning more than 5 years after menopause were...
12/28/2023